Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice.
Lauterbach
Henning
H
Department of Research, Bavarian Nordic GmbH, Martinsried, Germany. henning.lauterbach@bavarian-nordic.com
Kassub
Ronny
R
Pätzold
Juliane
J
Körner
Jana
J
Brückel
Michael
M
Verschoor
Admar
A
Chaplin
Paul
P
Suter
Mark
M
Hochrein
Hubertus
H
D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology; D003140:Communicable Disease Control; D003165:Complement System Proteins; D016207:Cytokines / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005434:Flow Cytometry / Q000379:methods; D007107:Immune System; D007114:Immunization; D007694:Killer Cells, Natural / Q000166:cytology; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D014612:Vaccines / Q000627:therapeutic use*; D014616:Vaccinia virus / Q000276:immunology*
D016207:Cytokines; D014612:Vaccines; D003165:Complement System Proteins